Literature DB >> 12228830

Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.

Richard Frothingham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12228830     DOI： 10.1086/342564

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

Review 1.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

Review 2.  Modern antifungal therapy for neutropenic fever.

Authors:  Melissa Corey
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

3.  Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations.

Authors:  Stefan Weiler; Gerda Falkensammer; Angelika Hammerer-Lercher; Markus Anliker; Helene Vogelsinger; Michael Joannidis; Stefan Dunzendorfer; Markus Stein; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

4.  Modern antifungal therapy for neutropenic fever.

Authors:  Melissa Corey
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

5.  Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.

Authors:  Peter Ball
Journal:  Curr Ther Res Clin Exp       Date:  2003-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.